Analysts are intrested in these 5 stocks: ( (PK) ), ( (TEM) ), ( (LX) ), ( (EIX) ) and ( (SRE) ). Here is a breakdown of their recent ratings and the rationale behind them.
Analysts see Park Hotels & Resorts stepping up its game, with BMO’s Ari Klein upgrading PK to Buy and targeting $18 as the company reshapes its portfolio. The strategy focuses on a leaner core of 20 higher‑quality hotels, supported by strong demand in Miami and Hawaii, and a healthier revenue mix that could drive faster growth and better margins into 2027 and beyond.
The growth story for Park is anchored in post‑renovation performance at the Royal Palm in Miami and a continuing recovery in Hawaii, both expected to add meaningful EBITDA over the next few years. While higher leverage, tax rebate reversals and property sales create short‑term headwinds, Klein argues PK’s valuation discount to other lodging REITs leaves room for upside as earnings and cash flow improve.
Tempus AI is back in favor with Piper Sandler’s David Westenberg upgrading TEM to Overweight and lifting the price target to $76, signaling renewed confidence in its AI‑driven healthcare model. The call highlights that earlier trading was driven more by broad AI enthusiasm than fundamentals, but three concrete growth drivers around diagnostics, data and regulatory milestones are now coming into clearer focus.
Central to the bullish view on Tempus is its pending Personalis acquisition, which adds a respected tumor‑informed MRD platform and strengthens its position in individualized mRNA therapies after positive INTerpath‑001 data. Combined with FDA approval for a key companion diagnostic and the potential for unified pricing, analysts see a richer revenue opportunity, even as they flag deal‑closing, financing and reimbursement risks investors must watch.
Lexinfintech Holdings finds itself on a tougher footing, with analyst Judy Zhang at a major bank downgrading LX to Neutral/High Risk and slashing the target to $1.20 amid tightening funding and rising asset quality concerns. Second‑quarter profit fell sharply, and higher provisions and funding costs squeezed margins, even as the e‑commerce business showed solid growth and improved profitability.
The real worry for Lexinfintech is what lies ahead, as management expects loan volumes to plunge by about 60% in the third quarter following a sector‑wide funding shock tied to the Juzi incident. The company is pausing interim dividends, staying cautious on buybacks, and focusing on capital‑heavy lending, moves that underline a more defensive stance in an environment where funding supply and credit quality are both under pressure.
Edison International, long seen as a key play on California’s energy transition, faces a more cautious outlook after BofA’s Ross Fowler cut EIX to Neutral and trimmed the price objective to $51. Investors had hoped new legislation, SB 492, would overhaul wildfire liability rules, but instead it improves survivor protections while leaving the core utility risk framework largely unchanged.
With no cap on liabilities, no meaningful reform to inverse condemnation and continued uncertainty around the state’s Wildfire Fund, analysts argue that policy risk now warrants a much wider valuation discount. Edison’s dividend looks intact, but with wildfire exposure still high and clarity unlikely until at least 2027, the stock may struggle to reclaim its former premium until a more durable solution emerges.
Sempra Energy offers a more optimistic counterpoint, as Jefferies’ Julien Dumoulin Smith upgrades SRE to Buy, calling it a case of “darkest before dawn” in Texas and California. The stock has de‑rated to a sizable P/E discount versus regulated peers due to transmission and legislative worries, yet analysts believe its investment plan, especially through Oncor in Texas, largely remains on track.
Jefferies sees Sempra’s earnings power supported by robust EPS growth and lower wildfire risk than California‑heavy peers PCG and EIX, with market fears overshooting actual transmission exposure. While full rerating likely waits on Texas legislative clarity and ongoing California rate and return reviews, the firm views current levels as offering limited downside and attractive risk‑reward for investors willing to be patient.